Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total

Not Applicable (1)

P 4 (1)

Trial Status

Completed3

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (3)

Showing 3 of 3 trials

NCT03196583Not ApplicableCompleted

Efficacy of a Novel MAD in OSA

NCT00849043Completed

Extension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopnea

NCT00772044Phase 4Completed

Randomized Study of Provent Versus Sham Device to Treat Obstructive Sleep Apnea

Showing all 3 trials

OSAH